Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesChemistry ProceduresCPT cpt-84436-thyroxine-t4-total-blood-test
    Ask Trek AI about this page

    CPT 84436: Thyroxine (T4) Measurement, Serum

    Commercial payers pay $20 on average nationally for this procedure.

    CPT code 84436 represents a laboratory assay that measures total thyroxine (T4) concentration in a blood/serum specimen; this is a clinical laboratory test used to evaluate thyroid function and is typically performed in a clinical laboratory or hospital laboratory using venous blood obtained by routine phlebotomy.

    For related coverage guidance, see recent payer policy updates: Diabetic Supplies, Radiofrequency Ablation for Thyroid Nodules, Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes (for Idaho Only).

    Customize your policy alerts

    Sign up for cpt 84436 policy alerts

    Get alerted when payer policies referencing 84436 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    National commercial reimbursements for CPT 84436 cluster around BUCA’s average commercial rate of $19.70, with variation across major carriers. Blue Cross Blue Shield shows a high mean and median ($29.50 and $27.40) while Aetna, Cigna, and UnitedHealth Group sit substantially lower (means $6.50, $7.60, and $6.00 respectively). BUCA’s mean of $19.70 represents an intermediate commercial benchmark between the lower-paying national commercial carriers and the outlying higher Blue Cross Blue Shield rates.

    Dispersion measured as P75 minus P25 highlights where rates are tightest or widest: Aetna’s interquartile range is $2.90 ($7.90 - $5.00), Cigna’s is $5.40 ($10.00 - $4.60), UnitedHealth Group’s is $3.90 ($6.90 - $3.00), Blue Cross Blue Shield’s is $14.20 ($36.70 - $22.50), and BUCA’s is $9.80 ($24.50 - $14.70). Blue Cross Blue Shield shows the widest IQR, Aetna the tightest.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 48-year-old female presents to her primary care clinic with fatigue, weight gain, cold intolerance, and dry skin. The clinician orders a serum total thyroxine (T4) assay to assess thyroid hormone levels as part of initial thyroid function testing and to follow up an abnormal thyroid stimulating hormone (TSH) result. A phlebotomist performs routine venipuncture in the outpatient clinic or hospital laboratory; the specimen is transported to the clinical laboratory. The lab analyst performs the 84436 assay (total T4) using appropriate immunoassay methodology. Results are reported in the electronic medical record and interpreted by the ordering clinician or an endocrinologist to guide diagnosis and management for conditions such as E03.9 (hypothyroidism), E05.90 (thyrotoxicosis), E06.3 (autoimmune thyroiditis), or to evaluate abnormal thyroid function studies (R94.6). Typical sites of service include outpatient clinic, ambulatory care laboratory, hospital outpatient laboratory, and inpatient hospital laboratory depending on patient presentation and care setting.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure

    Related Modifiers

    6 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    291U00000X
    207Q00000X
    207RE0101X
    2086S0129X
    103G00000X
    364SP0200X
    246QH0600X
    207ZF0201X

    Related ICD-10-CM Codes

    30 rows

    ICD-10-CM CodeDescription
    E00.9Congenital iodine-deficiency syndrome, unspecified
    E02Subclinical iodine-deficiency hypothyroidism
    E03.8Other specified hypothyroidism
    E03.9Hypothyroidism, unspecified
    E04.9Nontoxic goiter, unspecified
    E05.00Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm
    E05.01Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm
    E05.90Thyrotoxicosis, unspecified without thyrotoxic crisis or storm
    E06.3Autoimmune thyroiditis
    E06.9Thyroiditis, unspecified

    Showing 1–10 of 30

    Related Payer Policy Updates

    Specialty: Endocrinology1 / 3

    10 rows

    PolicyPayerEffective Date
    Diabetic SuppliesCigna2026-10-15
    Radiofrequency Ablation for Thyroid NodulesCigna2026-10-15
    Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes (for Idaho Only)UnitedHealthcare2026-10-01
    Continuous Glucose Monitoring and Insulin Delivery for Managing Diabetes (for Indiana Only)UnitedHealthcare2026-10-01
    Tzield (teplizumab-mzwv) CoverageUnitedHealthcare2026-10-01
    Medical Necessity Guidelines Insulin PumpsMass General Brigham Health Plan2026-10-01
    Medical Necessity Guidelines: Continuous Glucose MonitorsMass General Brigham Health Plan2026-10-01
    Continuous Glucose MonitoringAmbetter Nevada2026-10-01
    Salivary Hormone TestingOscar Health2026-10-01
    Bone Turnover Markers TestingOscar Health2026-10-01

    Related Codes

    CPT-82009-KETONE-BODIES-QUALITATIVE-TEST

    CPT 82009: Qualitative Ketone Bodies Test

    CPT-82010-QUANTITATIVE-KETONE-BODIES-ASSAY-SERUM-PLASMA

    CPT 82010: Quantitative Ketone Bodies in Serum or Plasma

    CPT-82013-ACETYLCHOLINESTERASE-QUANTITATIVE-ASSAY

    CPT 82013: Quantitative Acetylcholinesterase (Acetylhydrolase) Assay

    CPT-82016-QUALITATIVE-ACYLCARNITINES-METABOLIC-SCREEN

    CPT 82016: Qualitative Acylcarnitines, Plasma/Serum/Urine

    CPT-82017-QUANTITATIVE-ACYLCARNITINE-ANALYSIS

    CPT 82017: Quantitative Acylcarnitine Analysis

    CPT-82024-QUANTITATIVE-CORTICOTROPIN-ACTH-ASSAY

    CPT 82024: Adrenocorticotropic Hormone (ACTH) Quantitative Assay

    CPT-82030-QUANTITATIVE-CAMP-PLASMA-URINE-ASSAY

    CPT 82030: Quantitative cyclic AMP assay on plasma or urine

    CPT-82040-QUANTITATIVE-ALBUMIN-MEASUREMENT

    CPT 82040: Quantitative Albumin Measurement

    CPT-82042-QUANTITATIVE-ALBUMIN-NONBLOOD-FLUID

    CPT 82042: Albumin Quantitation in Non-Blood Body Fluid

    CPT-82043-URINE-ALBUMIN-QUANTITATION-KIDNEY-DISEASE

    CPT 82043: Urine Albumin Quantitative Assay

    Showing 1–10 of 411

    • More pages

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    84439
    Thyroxine; free
    Free T4 is often ordered alongside total T4 to distinguish bound versus unbound hormone and refine thyroid function interpretation.
    84443Thyroid stimulating hormone (TSH)TSH is the primary screening and monitoring test for thyroid dysfunction and is commonly ordered before or with 84436.
    84479Thyroid hormone (T3 or T4) uptake or thyroid hormone binding ratio (THBR)T3/T4 uptake or THBR may be ordered with total T4 to assess thyroid-binding capacity and improve interpretation of total T4 results.